Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 7
1992 26
1993 6
1994 6
1995 19
1996 14
1997 14
1998 14
1999 15
2000 17
2001 15
2002 20
2003 20
2004 9
2005 22
2006 15
2007 14
2008 9
2009 14
2010 15
2011 15
2012 15
2013 18
2014 17
2015 18
2016 24
2017 23
2018 25
2019 19
2020 22
2021 15
2022 21
2023 21
2024 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

507 results

Results by year

Filters applied: . Clear all
Page 1
Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation.
Plotkin SR, Messiaen L, Legius E, Pancza P, Avery RA, Blakeley JO, Babovic-Vuksanovic D, Ferner R, Fisher MJ, Friedman JM, Giovannini M, Gutmann DH, Hanemann CO, Kalamarides M, Kehrer-Sawatzki H, Korf BR, Mautner VF, MacCollin M, Papi L, Rauen KA, Riccardi V, Schorry E, Smith MJ, Stemmer-Rachamimov A, Stevenson DA, Ullrich NJ, Viskochil D, Wimmer K, Yohay K; International Consensus Group on Neurofibromatosis Diagnostic Criteria (I-NF-DC); Huson SM, Wolkenstein P, Evans DG. Plotkin SR, et al. Genet Med. 2022 Sep;24(9):1967-1977. doi: 10.1016/j.gim.2022.05.007. Epub 2022 Jun 9. Genet Med. 2022. PMID: 35674741 Free article.
Neurofibromatosis type 2.
Asthagiri AR, Parry DM, Butman JA, Kim HJ, Tsilou ET, Zhuang Z, Lonser RR. Asthagiri AR, et al. Lancet. 2009 Jun 6;373(9679):1974-86. doi: 10.1016/S0140-6736(09)60259-2. Epub 2009 May 22. Lancet. 2009. PMID: 19476995 Free PMC article. Review.
Neurofibromatosis Type 2.
Ardern-Holmes S, Fisher G, North K. Ardern-Holmes S, et al. J Child Neurol. 2017 Jan;32(1):9-22. doi: 10.1177/0883073816666736. Epub 2016 Sep 29. J Child Neurol. 2017. PMID: 27655473 Review.
Neurofibromatosis type 2.
Evans DG. Evans DG. Handb Clin Neurol. 2015;132:87-96. doi: 10.1016/B978-0-444-62702-5.00005-6. Handb Clin Neurol. 2015. PMID: 26564072 Review.
Neurofibromatosis type 2.
Evans GR, Lloyd SKW, Ramsden RT. Evans GR, et al. Adv Otorhinolaryngol. 2011;70:91-98. doi: 10.1159/000322482. Epub 2011 Feb 24. Adv Otorhinolaryngol. 2011. PMID: 21358190 Review.
Neurofibromatosis type 2.
Evans DG, Sainio M, Baser ME. Evans DG, et al. J Med Genet. 2000 Dec;37(12):897-904. doi: 10.1136/jmg.37.12.897. J Med Genet. 2000. PMID: 11106352 Free PMC article. Review.
Neurofibromatosis 2.
Kitamura K, Takahashi K, Kakoi H. Kitamura K, et al. Adv Otorhinolaryngol. 2000;56:244-8. doi: 10.1159/000059108. Adv Otorhinolaryngol. 2000. PMID: 10868241 Review. No abstract available.
Diagnosis of sporadic neurofibromatosis type 2 in the paediatric population.
Anand G, Vasallo G, Spanou M, Thomas S, Pike M, Kariyawasam DS, Mehta S, Parry A, Durie-Gair J, Nicholson J, Lascelles K, Everett V, Gibbon FM, Jarvis N, Elston J, Evans DG, Halliday D. Anand G, et al. Arch Dis Child. 2018 May;103(5):463-469. doi: 10.1136/archdischild-2017-313154. Epub 2018 Mar 13. Arch Dis Child. 2018. PMID: 29535107
507 results